Top compounds associated with response to TCERG1L


Feature Type Standardized
Nominal ANOVA
mRNA GMX-1778 CTRPv2 pan-cancer AAC 0.17 7e-07
mRNA PL-DI CTRPv2 pan-cancer AAC 0.15 8e-07
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 8e-07
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.15 2e-06
mRNA BRD-K94991378 CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 3e-06
mRNA PD-0325901 GDSC1000 pan-cancer AAC -0.16 3e-06
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.15 4e-06
Download CSV